Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Article in The Lancet Neurology (May 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Article in The Lancet Neurology (May 2024)
Article in Applied Sciences (February 2024)
Article in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (January 2024)